Clinical Trial Update: Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for human mesenchymal stromal cells in adults with acute respiratory distress syndrome (ARDS/Respiratory Distress Syndrome).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• human mesenchymal stromal cells

Snippet

Sponsor: Michael A. Matthay | Conditions: Respiratory Distress Syndrome, Adult | Phase 2 | Status: COMPLETED | Results posted: 2019-04-10